Le Lézard
Classified in: Science and technology
Subjects: Conference, Trade Show, Business Update

Growing Demand for Ausdia's Design Constraint Verification and Management Solution Leads to Expansion in Asia Pac Region


DVCon INDIA ? Ausdia, the leading provider of design constraint verification and management solutions that complement timing signoff for complex system-on-chip (SoC) designs, has expanded its regional offices in India, adding an office in Noida, Uttar Pradesh, India. This additional location will support increasing customer demand for the company's flagship product TimevisionTM. Pradeep CR, senior technical account manager for Ausida in India, will manage both locations in Bengaluru and Noida.

"Do to the growing demand in Asia Pac under Pradeep's leadership, we are now able to provide customers with high quality, personable support in multiple regions, " said Sam Appleton, CEO, Ausdia. "This expansion continues Ausdia's commitment to our customers and the region to address the challenges of SoC designs."

About Timevision Platform

The Timevision platform integrates a variety of formal, structural and simulation-based technologies to aid STA engineers in the quick and confident development of constraints from high-level data. This groundbreaking approach allows STA engineers to dramatically increase their productivity by operating as constraint synthesizers, rather than line-by-line writers and debuggers.

Ausdia will be showcasing the Timevision platform and the company's latest technology advances at DVCon India, in booth #18. Included in the demonstration will be the new enhancement, Timevision SC that was recently announced at the 60th Design Automation Conference (DAC) 2023.

Timevision SC allows constraint developers to both read and write timing constraints in a Spreadsheet format ? typically ExcelTM. This empowers users to express their design intentions in a simple, reviewable format, with Timevision automation taking care of the complexities of translation to exact SDC syntax. Users can also export existing SDC to SC (Spreadsheet Constraints) format for simplified review and porting.

About Ausdia

Ausdia delivers standout timing constraint development, verification, and management solutions that complement all implementation and timing signoff flows. The company's groundbreaking methodology and products give system-on-chip (SoC) and integrated circuit (IC) developers a new way to work, enabling massive productivity gains throughout the design flow. Founded in 2006, the privately held company is headquartered in Sunnyvale, California.

Ausdia acknowledges trademarks or registered trademarks of other organizations for their respective products and services.


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: